Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesRTW Venture Fund Ltd

RTW Venture Fund Ltd

Financial Services Asset Management
PortfolioPortfolio WatchlistWatchlist
Company price
2.39 GBX 0.06 ( 2.58%)
Last update at 2026-10-27T16:35:00Z
VOLUME
289704
Market Cap
66406.82M
P/E
0.03

Momentum Score

…

RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.30
Low
2.39
High
52 Week Price Range
1.11
Low
2.32
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
2.33
Dividend Yield
-
Revenue TTM
34.57M
Revenue Per Share
0.11
Gross Profit TTM
34.57M
Debt / Equity
0.16
ROE
32.74%
Net Debt
-5.99M
ROCE
23.82%
Diluted EPS TTM
0.63

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 245.19M 34.18M 83.19M -39.44M -64.34M
Net income 245.19M 34.18M 83.19M -39.44M -64.34M
Selling general administrative 5.69M 4.55M 3.10M 2.93M 3.43M
Gross profit 250.89M 38.73M 67.02M -36.51M -60.92M
Ebit - 34.92M 81.76M - -7.58M
Ebitda 245.19M 38.89M 84.75M -38.66M -64.34M
Depreciation and amortization - 3.97M 2.99M - -
Operating income 245.19M 38.89M -2.99M -38.66M -64.34M
Other operating expenses 12.82M 9.32M 4.66M 2.93M 3.43M
Interest expense 7.13M 4.77M 1.56M 0.78M 0.22M
Interest income 7.02M 6.35M 2.42M 0.64M 0.36M
Net interest income -0.11M 1.58M 0.86M -0.14M 0.15M
Income tax expense - - 83.19M - -
Total revenue 258.01M 43.50M 87.86M -36.51M -60.92M
Total operating expenses 5.69M 4.55M 7.16M 2.93M 3.43M
Cost of revenue 7.13M 4.77M 4.27M - -
Total other income expense net - 112.08M 85.71M -0.78M -0.22M
Net income from continuing ops 245.19M 34.18M 83.19M -39.44M -64.34M
Net income applicable to common shares - - - - -64.34M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1069.04M 760.02M 446.23M 401.54M 439.36M
Other current assets - -4.24M 48.68M - 10.98M
Total liab 203.82M 127.37M 17.21M 53.62M 0.49M
Total stockholder equity 865.22M 606.92M 399.28M 347.92M 387.36M
Other current liab 39.42M 8.65M 10.68M -5.56M -0.49M
Common stock - 606.92M 399.28M - 363.04M
Other assets - 33.47M -46.13M 22.54M 0.19M
Cash 5.99M 5.36M 2.72M 6.97M 6.48M
Total current liabilities 39.85M 127.37M 17.21M 5.56M 0.49M
Current deferred revenue - - -1.20M - -
Net debt -5.99M -5.36M -2.72M -6.97M -6.48M
Short term debt - 95.15M 1.20M - -
Short long term debt total - 95.15M 1.20M - -
Other stockholder equity 865.22M 632.64M 29.74M - 387.36M
Total current assets 5.99M 5.36M 109.29M 7.41M 19.01M
Long term investments 941.11M 721.19M 383.08M 371.59M 420.16M
Net tangible assets - - - - 387.36M
Net receivables - 4.24M 57.89M 22.64M 12.52M
Inventory - - -106.56M - -
Accounts payable 0.44M 23.57M 5.33M 5.56M 0.49M
Non currrent assets other 916.26M -721.19M -383.08M -371.59M -420.16M
Non current assets total 1063.06M 721.19M 383.08M 371.59M 420.16M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - - 0.00M
Total cash from financing activities - 97.08M -2.09M - 39.09M
Change to operating activities - - - - 37.92M
Net income 245.19M 34.18M 83.19M -39.44M -64.34M
Change in cash 92.64M -27.26M 31.45M 10.35M -5.78M
Begin period cash flow 33.35M 60.61M 29.16M 18.81M 24.59M
End period cash flow 125.99M 33.35M 60.61M 29.16M 18.81M
Total cash from operating activities 105.25M -124.34M 33.54M 10.35M -44.87M
Issuance of capital stock 0.00M 108.42M 0.00M 0.00M 44.07M
Other cashflows from investing activities - 85.82M -70.86M - -
Dividends paid - - - 0.00M 4.97M
Change to account receivables - -4.24M -5.12M - 0.83M
Sale purchase of stock -12.61M -11.34M -2.09M - -
Other cashflows from financing activities - - 70.86M - -
Change to netincome - - - - -19.28M
Capital expenditures 0.00M 38.52M 37.32M 0.00M 0.00M
Change in working capital 19.78M 14.24M -26.39M -7.52M 38.75M
Other non cash items -0.00M -172.76M -23.26M 57.31M -19.28M
Free cash flow 105.25M -124.34M 70.86M 10.35M -44.87M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
RTW
RTW Venture Fund Ltd		 0.06
2.58%		 2.39 0.03 - 19.21 0.76 2.61
MNTN
Schiehallion Fund Ltd		 -0.01
0.46%		 2.18 0.05 - 4.35 1.25 5.65
BHMU
BH Macro Limited		 -
-%		 4.29 0.09 - 39.01 0.71 6.47
TFG
Tetragon Financial Group Ltd		 0.15
1.00%		 15.10 0.02 7.04 1.16 0.31 2.06
BPCR
BioPharma Credit PLC		 0.00
0.41%		 0.98 0.09 - 6.73 0.91 7.95

Profile*

RTW Venture Fund Ltd

RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

40 10th Avenue, New York, NY, United States, 10014

646 597 6980

https://www.rtwfunds.com/rtw-biotech-opportunities

Name Title Year Born
Baroness Nicola Blackwood Senior Independent Non-Executive Director 1979
Dr. Roderick Tze Ian Wong M.B.A., M.D. Investment Professional 1977
Mr. Woody Stileman Investment Professional NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…